Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Azure Cell Therapies is a biotech company developing next-gen CGTs for neurodegenerative diseases
High-Impact Preventive Healthcare That Works
Gain Therapeutics is a biotech company developing pharmacological chaperones drugs designed to treat rare metabolic disorders.
Biosimo Chemicals produces sustainable chemicals
Cryowrite is a sample preparation for cryo-electron microscopy.
Topadur Pharma is a biopharmaceutical company that develops healthcare drugs for the treatment of aging diseases and medical ailments.
Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.
Zynnon develops solutions for risk respiratory infection transmission in hospitals and health facilities.
Aldena Therapeutics is a private biotech startup that invented siRNA-based treatments for dermatological conditions.
Wildbiene + Partner contributes to a balanced ecosystem by providing sustainable pollination and high-quality bee experiences.
Automating submerged asset inspections with a remote underwater drone platform
Nanoflex Robotics develops a telerobotic platform that enables remote treatment of ischemic strokes
Perovskia digitally prints custom solar cells based on patent-protected technology.
8links offers a multi-layer coating technique for scalable lithium-ion battery manufacture.
Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections through an AI-powered technology.
Aegis Rider is an augmented reality company that provides spatially anchored information to motorcyclists.
Cytronic AG is the brand for compact and user-friendly linear drives and the market leader with the worldwide unique electric cylinder.
Adoram Therapeutics is a company that uses the benefits of allosteric biochemistry to develop novel therapies.
Noriware is a packaging materials manufacturing company that offers seaweed-based packaging film composed of natural materials.
OncoSwab is creating a point-of-care test to detect lung cancer in high-risk individuals.
Encelta T-cell therapy target and eliminate both blood cancers and solid tumors combined with bispecific antibodies.
KOMP-ACT develops innovative electric motion technology for the industrial automation industry for a carbon-neutral future.
Ammonia for Clean Energy - Driving Clean, Sustainable Off-Grid Power Solution
Komed Health is a healthcare collaboration platform that streamlines clinical workflows.
Innosuisse has invested in 213 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Innosuisse's top investment sectors include Biotechnology, Health Care, Biopharma, Therapeutics, Renewable Energy. The firm invests across 44 different industry categories.
Among tracked funding rounds, Gain Therapeutics received $7.0M in a Post-IPO Equity round. Innosuisse's total known invested capital is $462.1M.
Innosuisse's average investment size is $2.8M across its portfolio of 213 companies.
Recent Innosuisse portfolio additions include Azure Cell Therapies, Nutrix, Gain Therapeutics, Biosimo, Cryowrite. These companies were founded in 2020 or later.